Diagnostic and pathology laboratories chain Dr Lal Pathlabs Ltd on Monday received markets regulator Securities and Exchange Board of India’s approval for its initial public offering (IPO), according to data on the regulators website.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
